PLSE (Pulse Biosciences Inc) Return on Sales by Gross Profit

PLSE (Pulse Medical) - company brandmark

Pulse Biosciences, Inc. (PLSE) is developing an innovative nanopulse stimulation method, seeking FDA approval in cardiology and oncology. The gross margin level allows for tracking the impact of costs on profitability, where 0.70 characterizes this valuation parameter. However, success depends on physician adoption of the technology and funding, while the strategy relies on expanding clinical trials in dermatology and surgery.

Pulse Biosciences, Inc. (PLSE): Gross Margin from 07/04/2022 to 11/19/2026

Comprehensive metric breakdowns and analytics for Pulse Biosciences, Inc. (PLSE)

Fundamental valuation:PLSE Pulse Biosciences Inc
Finished products of Pulse Medical

To select high-quality assets, an investor must evaluate a business's ability to generate profit over direct costs. This metric measures the portion of revenue minus production expenses, which in the case of Pulse Biosciences, Inc. (PLSE) reflects the efficiency of utilizing external contract manufacturing plants and cloud services, while the gross margin trend after deducting cost of goods sold demonstrates the real operational return from innovative treatment methods.

Main competitors

Gross Return on Sales DXCM|PEN (Penumbra Medical) - Gross Margin|Novanta Corp (NOVT) - Return on Sales by Gross Profit|Gross Margin HAE|Return on Gross Profit Inspire Medical Systems INSP|Gross Margin PRCT (procept-biorobotics.com)|Gross Margin CONMED Corp CNMD|INMD - Gross Profitability|Gross Profit Rate PMI (Picard Medical Inc.)|SRDX (Surmodics, Inc.) - Return on Gross Profit|Eversense - Gross Profit Rate|NPCE (NeuroPace Medical) - Gross Margin|Gross Profit Margin tactilemedical.com TCMD|Gross Profitability SANUWAVE Health (SNWV)|Return on Sales by Gross Profit Outset Medical Corp|SmartVest - Return on Gross Profit|Gross Margin LENSAR, Inc. LNSR|AVITA Medical Inc. - Gross Margin|Return on Sales by Gross Profit Profound Medical PROF|Baird Medical (BDMD) - Gross Profitability|Gross Profitability Margin EDAP (EDAP Medical)|Gross Profitability apyxmedical.com|Return on Gross Profit IceCure Medical Ltd (ICCM)|Gross Margin LUNG|TELA - Gross Profit Margin|Gross Profitability cytosorbents.com CTSO|SRTS: Gross Return on Sales|ZYXI: Return on Gross Profit|electrocore.com - Gross Profit Ratio|RBOT (Vicarious Surgical Inc) - Return on Gross Profit|IINN - Return on Sales by Gross Profit|ICU (SeaStar Medical Holding Corporation) - Gross Margin|IRIX: Gross Profit Rate|Return on Gross Profit INBS (Intelligent Bio Solutions)|XAIR - Gross Profit Margin|Gross Margin PFSA (Profusa Inc)|Gross Margin strataskinsciences.com SSKN|GCTK - Gross Profitability|NAOV: Gross Profitability|VERO (Venus Concept Inc.) - Return on Gross Profit|NUWE (Nuwellis, Inc.) - Gross Profitability|Gross Profitability Aethlon|Asensus Surgical (ASXC) - Return on Sales by Gross Profit|Return on Gross Profit AVGR (Avinger, Inc)|Gross Profit Ratio BSGM|Gross Profitability Cutera CUTR|Gross Profit Rate KNW|Inari Medical Inc - Gross Margin|Gross Profitability Margin NVRO|RSLS: Gross Margin|Return on Gross Profit Silk Road Medical Inc.